T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
626
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $158M | 0.02% |
3,874,066
-189,057
| -5% | -$7.7M |
|
627
Arvinas
ARVN
$575M
| $158M | 0.02% |
2,386,455
+141,006
| +6% | +$9.32M |
|
628
New Oriental
EDU
$9.04B
| $158M | 0.02% |
1,126,140
+745,538
| +196% | +$104M |
|
629
Apellis Pharmaceuticals
APLS
$3.29B
| $156M | 0.02% |
3,642,149
+596,820
| +20% | +$25.6M |
|
|
AESC
630
DELISTED
The AES Corporation
AESC
| $156M | 0.02% |
+1,516,303
| New | +$156M |
|
631
Consolidated Edison
ED
$35B
| $155M | 0.02% |
2,075,987
+1,489,003
| +254% | +$111M |
|
632
Fox Class A
FOXA
$25.5B
| $155M | 0.02% |
4,282,958
+737,316
| +21% | +$26.6M |
|
633
Atea Pharmaceuticals
AVIR
$250M
| $154M | 0.02% |
2,561,375
+43,398
| +2% | +$2.61M |
|
634
Agios Pharmaceuticals
AGIO
$2.07B
| $153M | 0.02% |
2,960,412
-11,910
| -0.4% | -$615K |
|
|
CHX
635
DELISTED
ChampionX
CHX
| $152M | 0.02% |
7,007,340
-60,263
| -0.9% | -$1.31M |
|
636
RenaissanceRe
RNR
$11.2B
| $152M | 0.02% |
949,215
+878,478
| +1,242% | +$141M |
|
637
United Airlines
UAL
$34.8B
| $152M | 0.02% |
2,636,052
-246,361
| -9% | -$14.2M |
|
638
ICICI Bank
IBN
$113B
| $152M | 0.02% |
9,454,777
+592,485
| +7% | +$9.5M |
|
|
NBIS
639
Nebius Group N.V. Class A Ordinary Shares
NBIS
$22.3B
| $151M | 0.02% |
2,350,078
+220,333
| +10% | +$14.1M |
|
640
10x Genomics
TXG
$1.57B
| $150M | 0.02% |
831,103
-25,183
| -3% | -$4.56M |
|
|
WBA
641
DELISTED
Walgreens Boots Alliance
WBA
| $150M | 0.02% |
2,736,639
+1,482,468
| +118% | +$81.4M |
|
642
Delta Air Lines
DAL
$40.1B
| $150M | 0.02% |
3,110,785
+829,564
| +36% | +$40.1M |
|
643
Novavax
NVAX
$1.29B
| $149M | 0.01% |
822,768
+476,750
| +138% | +$86.4M |
|
|
BECN
644
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $149M | 0.01% |
2,841,579
-14,263
| -0.5% | -$746K |
|
645
AtriCure
ATRC
$1.75B
| $148M | 0.01% |
2,265,628
-65,805
| -3% | -$4.31M |
|
646
Expro
XPRO
$1.42B
| $148M | 0.01% |
6,960,970
+284,114
| +4% | +$6.05M |
|
647
Hanover Insurance
THG
$6.37B
| $148M | 0.01% |
1,142,767
+57,223
| +5% | +$7.41M |
|
648
NVR
NVR
$23B
| $148M | 0.01% |
31,333
+995
| +3% | +$4.69M |
|
|
OZON
649
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $147M | 0.01% |
2,628,672
-411,857
| -14% | -$23.1M |
|
650
Peloton Interactive
PTON
$3.2B
| $147M | 0.01% |
1,309,455
+389,676
| +42% | +$43.8M |
|